Abstract
In this era of effective combination antiretroviral therapy the incidence of AIDS defining cancers (ADCs) is projected to decline while the incidence of certain non-AIDS defining cancers (NADCs) increases. Some of these NADCs are potentially preventable with appropriate cancer screening. We examined cancer incidence, screening eligibility, and receipt of screening among persons actively enrolled in the DC Cohort, a longitudinal observational cohort of PLWH, between 2011 and 2017. Cancer screening eligibility was determined based on age, sex, smoking history and co-morbidity data available and published national guidelines. The incidence rate of NADCs was 12.1 (95% CI 10.7, 13.8) and ADCs 1.6 (95% CI 0.6, 4.6) per 1000 person-years. The most common incident NADCs were breast 2.6 (95% CI 0.5,1 2.1), prostate 2.3 (95% CI 1.2, 4.3), and non-melanoma skin 1.2 (95% CI 0.6, 2.3) incident diagnoses/cases per 1000 person-years. Among cohort sites where receipt of cancer screening was assessed, less than 60% of eligible participants had any ascertained anal HPV, breast, cervical, colorectal, hepatocellular carcinoma, or lung cancer screening. In this cohort of PLWH, there were more incident NADCs versus ADCs in contrast to earlier cohort studies where ADCs predominated. Despite a large eligible population there were low rates of screening. Implementation of cancer screening is an important component of care among PLWH.
Similar content being viewed by others
References
Collaboration, A. T. C. (2017). Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. The Lancet HIV, 4(8), e349–e356.
Porter, K., Babiker, A., Bhaskaran, K., Darbyshire, J., Pezzotti, P., Porter, K., et al. (2003). Determinants of survival following HIV-1 seroconversion after the introduction of HAART. The Lancet, 362(9392), 1267–1274.
Smith, C. J., Ryom, L., Weber, R., Morlat, P., Pradier, C., Reiss, P., & D:A:D Study Group. (2014). Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration. The Lancet, 384(9939), 241–248.
Centers for Disease Control and Prevention. (2017). HIV Surveillance Report, 2016; 28. https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html.
Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Jr., Klein, D. B., et al. (2016). Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. Journal of Acquired Immune Deficiency Syndromes, 73(1), 39–46.
Kochanek KD, Murphy SL, Xu JQ, Arias E. (2017). Mortality in the United States, 2016. NCHS Data Brief, no 293. https://www.cdc.gov/nchs/products/databriefs/db293.htm.
Riedel, D. J., Tang, L. S., & Rositch, A. F. (2015). The role of viral co-infection in HIV-associated non-AIDS-related cancers. Current HIV/AIDS Reports, 12(3), 362–372.
Hernández-Ramírez, R. U., Shiels, M. S., Dubrow, R., & Engels, E. A. (2017). Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. The Lancet HIV. https://doi.org/10.1016/S2352-3018(17)30125-X.
Yarchoan, R., & Uldrick, T. S. (2018). HIV-associated cancers and related diseases. The New England Journal of Medicine, 378(11), 1029–1041.
Shiels, M. S., Islam, J. Y., Rosenberg, P. S., Hall, H. I., Jacobson, E., & Engels, E. A. (2018). Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the united states through 2030. Annals of Internal Medicine, 168(12), 866–873.
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P., Zingman, B. S., & Horberg, M. A. et al. (2014). Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases, 58(1), 1–10.
Greenberg, A. E., Hays, H., Castel, A. D., Subramanian, T., Happ, L. P., & Jaurretche, M., et al. (2016). Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions. Journal of the American Medical Informatics Association, 23(3), 635–643.
Siu, A. L. (2016). Screening for breast cancer: US preventive services task force recommendation statement. Annals of Internal Medicine., 164(4), 279–296.
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K.-M., Hwang, J. P., Jonas, M. M., et al. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 67(4), 1560–1599.
Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., et al. (2018). AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology, 67(1), 358–380.
Yuan, Y. (2011). Multiple imputation using SAS software. Journal of Statistical Software, 45(6), 1–25.
Hessol, N. A., Seaberg, E. C., Preston-Martin, S., Massad, L. S., Sacks, H. S., & Silver, S., et al. (2004). Cancer risk among participants in the women’s interagency HIV study. Journal of Acquired Immune Deficiency Syndromes, 36(4), 978–985.
Park, L. S., Tate, J. P., Rodriguez-Barradas, M. C., Rimland, D., Goetz, M. B., Gibert, C., et al. (2014). Cancer incidence in HIV-infected versus uninfected veterans: comparison of cancer registry and ICD-9 code diagnoses. Journal of AIDS & Clinical Research, 5(7), 1000318.
Seaberg, E. C., Wiley, D., Martínez-Maza, O., Chmiel, J. S., Kingsley, L., & Tang, Y., et al. (2010). Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007. Cancer, 116(23), 5507–5516.
Silverberg, M. J., Lau, B., Achenbach, C. J., Jing, Y., Althoff, K. N., D’Souza, G., Engels, E. A., Hessol, N. A., Brooks, J. T., Burchell, A. N., Gill, M. J., Goedert, J. J., Hogg, R., Horberg, M. A., Kirk, G. D., Kitahata, M. M., Korthuis, P. T., Mathews, W. C., Mayor, A., … North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS. (2015). Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. Annals of Internal Medicine, 163(7), 507–518.
SEER Research Data 1973–2015. (n.d.). Retrieved September 6, 2018, from https://seer.cancer.gov/statfacts/html/all.html.
Omland, S. H., Ahlström, M. G., Gerstoft, J., Pedersen, G., Mohey, R., Pedersen, C., et al. (2018). Risk of skin cancer in patients with HIV: A Danish nationwide cohort study. Journal of the American Academy of Dermatology, 79(4), 689–695.
Silverberg, M. J., Leyden, W., Warton, E. M., Quesenberry, C. P., Jr., Engels, E. A., & Asgari, M. M. (2013). HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. Journal of the National Cancer Institute, 105(5), 350–360.
Zhao, H., Shu, G., & Wang, S. (2016). The risk of non-melanoma skin cancer in HIV-infected patients: New data and meta-analysis. International Journal of STD & AIDS, 27(7), 568–575.
Beachler, D. C., & DʼSouza, G., (2013). Oral human papillomavirus infection and head and neck cancers in HIV-infected individuals. Current Opinion in Oncology, 25(5), 503–510.
Workowski, K. A., and G. A. Bolan. (2015). Sexually transmitted diseases treatment guidelines. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports, 64, RR–03.
The Anchor Study. (n.d.). Retrieved January 28, 2019, from https://anchorstudy.org/.
Cervical Cancer Screening. (n.d.). Retrieved November 1, 2018, from https://progressreport.cancer.gov/detection/cervical_cancer.
Leece, P., Kendall, C., Touchie, C., Pottie, K., Angel, J. B., & Jaffey, J. (2010). Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic. Canadian Family Physician Medecin de Famille Canadien, 56(12), e425–e431.
Rahangdale, L., Sarnquist, C., Yavari, A., Blumenthal, P., & Israelski, D. (2010). Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States. Journal of Women’s Health, 19(4), 709–712.
Simonsen, S. E., Kepka, D., Thompson, J., Warner, E. L., Snyder, M., & Ries, K. M. (2014). Preventive health care among HIV positive women in a Utah HIV/AIDS clinic: A retrospective cohort study. BMC Women’s Health, 14(1), 37.
Goedert, J. J., Schairer, C., McNeel, T. S., Hessol, N. A., Rabkin, C. S., Engels, E. A. et al. (2006). Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. British Journal of Cancer, 95(5), 642–648.
Preston-Martin, S., Kirstein, L. M., Pogoda, J. M., Rimer, B., Melnick, S., Masri-Lavine, L., et al. (2002). Use of mammographic screening by HIV-infected women in the Women’s Interagency HIV Study (WIHS). Preventive Medicine, 34(3), 386–392.
Breast Cancer Screening. (n.d.). Retrieved November 1, 2018, from https://progressreport.cancer.gov/detection/breast_cancer.
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., et al. (2015). Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA, 314(15), 1599–1614.
Practice Bulletin, Number 179, July 2017, Breast Cancer Risk Assessment and Screening in Average-Risk Women. (n.d.). https://www.acog.org/-/media/Practice-Bulletins/Committee-on-Practice-Bulletins----Gynecology/Public/pb179.pdf?dmc=1&ts=20190108T2141432032.
Monticciolo, D. L., Newell, M. S., Hendrick, R. E., Helvie, M. A., Moy, L., Monsees, B., et al. (2017). Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. Journal of the American College of Radiology: JACR, 14(9), 1137–1143.
National Comprehensive Cancer Network. (2018). Breast Cancer Screening and Diagnosis. https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf.
McCormack, V. A., Febvey-Combes, O., Ginsburg, O., & Dos-Santos-Silva, I. (2018). Breast cancer in women living with HIV: A first global estimate. International Journal of Cancer, 143(11), 2732–2740.
Moyer, V. A. & & U.S. Preventive Services Task Force. (2014). Screening for lung cancer: U.S. Preventive services task force recommendation statement. Annals of Internal Medicine, 160(5), 330–338.
Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., Jr., García, F. A. R., et al. (2016). Screening for Colorectal Cancer: US preventive services task force recommendation statement. JAMA, 315(23), 2564–2575.
Pham, D., Bhandari, S., Oechsli, M., Pinkston, C.M., Kloecker, G.H. James Graham Brown Cancer Center, University of Louisville, Louisville, KY, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, US, University of Louisville, Louisville, KY, University of Louisville School of Public Health, Information Sciences, Louisville, KY, University of Louisville School of Medicine, Department of Internal Medicine, Division of Hematology, & Medical Oncology, James Brown Graham Cancer Center, Louisville, KY. (2018). Lung cancer screening rates: Data from the lung cancer screening registry. https://meetinglibrary.asco.org/record/158432/abstract.
Lung Cancer Screening. (n.d.). Retrieved November 1, 2018, from https://progressreport.cancer.gov/detection/lung_cancer.
Centers for Disease Control and Prevention (CDC). Quick Facts: Colorectal Cancer Screening in U.S. (n.d.). https://www.cdc.gov/cancer/colorectal/pdf/QuickFacts-BRFSS-2016-CRC-Screening-508.pdf.
Keller, S. C., Momplaisir, F., Lo Re, V., Newcomb, C., Liu, Q., Ratcliffe, S. J., et al. (2014). Colorectal cancer incidence and screening in US Medicaid patients with and without HIV infection. AIDS Care, 26(6), 716–722.
Horsky, J., Drucker, E. A., & Ramelson, H. Z. (2017). Accuracy and completeness of clinical coding using ICD-10 for ambulatory visits. AMIA ... Annual Symposium Proceedings/AMIA Symposium. AMIA Symposium, 2017, 912–920.
Acknowledgements
This work was supported by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health under Grant UM1 AI69503. Data was collected by the DC Cohort investigators and research staff at: Cerner Corporation (Jeffrey Binkley, Cheryl Akridge, Thilia Subramanian, Qingjiang Hou, Stacey Purinton, Nabil Rayeed, Rob Taylor); Children’s National Medical Center Adolescent (Lawrence D’Angelo) and Pediatric (Natella Rakhmanina) clinics; The Senior Deputy Director of the DC Department of Health HAHSTA (Michael Kharfen); Family and Medical Counseling Service (Michael Serlin); Georgetown University (Princy Kumar); George Washington Medical Faculty Associates(David Parenti); George Washington University Department of Epidemiology and Biostatistics (Anne Monroe, James Peterson, Lindsey Powers Happ, Maria Jaurretche, Brittany Wilbourn, and Kevin Trac); Howard University (Ronald Wilcox); La Clínica Del Pueblo (Ricardo Fernandez); MetroHealth (Annick Hebou); National Institutes of Health (Carl Dieffenbach);Unity Health Care (Gebeyehu Teferi); Veterans Affairs Medical Center (Debra Benator); Washington Hospital Center (Maria Elena Ruiz); Whitman‐Walker Health (David Hardy, Deborah Goldstein); Kaiser Permanente (Michael Horberg). We would also like to acknowledge the Research Assistants at all of the participating sites, the DC Cohort Community Advisory Board and the DC Cohort participants. This research has been facilitated by the services and resources provided by the District of Columbia Center for AIDS Research, an NIH funded program (AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NIDDK, NIMHD, NIDCR, NINR, FIC and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant disclosures to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Spence, A.B., Levy, M.E., Monroe, A. et al. Cancer Incidence and Cancer Screening Practices Among a Cohort of Persons Receiving HIV Care in Washington, DC. J Community Health 46, 75–85 (2021). https://doi.org/10.1007/s10900-020-00844-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10900-020-00844-6